Literature DB >> 30571141

Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Kunal J Patel1,2, Qi Cheng1,2,3, Sarah Stephenson4, D Patterson Allen2, Changhai Li1,2,3, Jane Kilkenny2, Ryan Finnegan1, Valeria Montalvo-Calero1, Scott Esckilsen2, Chentha Vasu1, Martin Goddard5, Satish N Nadig1,2,6, Carl Atkinson1,2,6.   

Abstract

Chronic obstructive pulmonary disease-associated chronic inflammation has been shown to lead to an autoimmune phenotype characterized in part by the presence of lung autoreactive antibodies. We hypothesized that ischemia-reperfusion injury (IRI) liberates epitopes that would facilitate preexisting autoantibody binding, thereby exacerbating lung injury after transplant. We induced emphysema in C57BL/6 mice through 6 months of cigarette smoke (CS) exposure. Mice with CS exposure had significantly elevated serum autoantibodies compared with non-smoke-exposed age-matched (NS) mice. To determine the impact of a full preexisting autoantibody repertoire on IRI, we transplanted BALB/c donor lungs into NS or CS recipients and analyzed grafts 48 hours after transplant. CS recipients had significantly increased lung injury and immune cell infiltration after transplant. Immunofluorescence staining revealed increased IgM, IgG, and C3d deposition in CS recipients. To exclude confounding alloreactivity and confirm the role of preexisting autoantibodies in IRI, syngeneic Rag1-/- (recombination-activating protein 1-knockout) transplants were performed in which recipients were reconstituted with pooled serum from CS or NS mice. Serum from CS-exposed mice significantly increased IRI compared with control mice, with trends in antibody and C3d deposition similar to those seen in allografts. These data demonstrate that pretransplant CS exposure is associated with increased IgM/IgG autoantibodies, which, upon transplant, bind to the donor lung, activate complement, and exacerbate post-transplant IRI.

Entities:  

Keywords:  autoantibodies; chronic obstructive pulmonary disease; complement; ischemia–reperfusion injury; lung transplant

Mesh:

Substances:

Year:  2019        PMID: 30571141      PMCID: PMC6543752          DOI: 10.1165/rcmb.2018-0224OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  51 in total

1.  Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.

Authors:  Carl Atkinson; Fei Qiao; Xiaofeng Yang; Peng Zhu; Nicholas Reaves; Liudmila Kulik; Martin Goddard; V Michael Holers; Stephen Tomlinson
Journal:  Circulation       Date:  2015-02-17       Impact factor: 29.690

2.  Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.

Authors:  Ankit Bharat; Deepti Saini; Nancy Steward; Ramsey Hachem; Elbert P Trulock; G Alexander Patterson; Bryan F Meyers; Thalachallour Mohanakumar
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

3.  Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.

Authors:  Deepti Saini; Joseph Weber; Sabarinathan Ramachandran; Donna Phelan; Venkataswarup Tiriveedhi; Michael Liu; Nancy Steward; Aviva Aloush; Ramsey Hachem; Elbert Trulock; Bryan Meyers; G Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2011-03-16       Impact factor: 10.247

4.  Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Authors:  Qi Cheng; Kunal Patel; Biao Lei; Lindsay Rucker; D Patterson Allen; Peng Zhu; Chentha Vasu; Paulo N Martins; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Transplant       Date:  2018-04-10       Impact factor: 8.086

Review 5.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

6.  α1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death.

Authors:  Wenxi Gao; Jinbo Zhao; Hyunhee Kim; Shuyun Xu; Manyin Chen; Xiaohui Bai; Hiroaki Toba; Hae-Ra Cho; Haibo Zhang; Shaf Keshavjeel; Mingyao Liu
Journal:  J Heart Lung Transplant       Date:  2013-10-25       Impact factor: 10.247

7.  Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression.

Authors:  Sivasubramanium Bhavani; Xiaoyi Yuan; Ran You; Ming Shan; David Corry; Farrah Kheradmand
Journal:  Ann Am Thorac Soc       Date:  2015-11

8.  Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation.

Authors:  V Subramanian; S Ramachandran; B Banan; A Bharat; X Wang; N Benshoff; D Kreisel; A E Gelman; T Mohanakumar
Journal:  Am J Transplant       Date:  2014-09-12       Impact factor: 8.086

9.  Activation of C3a receptor is required in cigarette smoke-mediated emphysema.

Authors:  X Yuan; M Shan; R You; M V Frazier; M J Hong; R A Wetsel; S Drouin; A Seryshev; L-Z Song; L Cornwell; R D Rossen; D B Corry; F Kheradmand
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

10.  A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury.

Authors:  Alex Woodell; Bryan W Jones; Tucker Williamson; Gloriane Schnabolk; Stephen Tomlinson; Carl Atkinson; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

View more
  6 in total

1.  Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation.

Authors:  Vaidehi Kaza; Chengsong Zhu; Leying Feng; Fernando Torres; Srinivas Bollineni; Manish Mohanka; Amit Banga; John Joerns; T Mohanakumar; Lance S Terada; Quan-Zhen Li
Journal:  Transpl Immunol       Date:  2020-01-30       Impact factor: 1.708

2.  Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.

Authors:  Usha Rao; Monal Sharma; Thalachallour Mohanakumar; Chul Ahn; Ang Gao; Vaidehi Kaza
Journal:  Transpl Immunol       Date:  2019-02-20       Impact factor: 1.708

Review 3.  Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant.

Authors:  Alexander McQuiston; Amir Emtiazjoo; Peggi Angel; Tiago Machuca; Jason Christie; Carl Atkinson
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

4.  Effect of Different Doses of Propofol on Pulmonary Function and Inflammatory Response in Patients with Lung Ischemia Reperfusion Injury Induced by One-Lung Ventilation Based on Big Data Analysis.

Authors:  Yi Gu; Xu Liu; Tianyu Gu; Boxiang Du
Journal:  J Healthc Eng       Date:  2022-04-21       Impact factor: 3.822

Review 5.  Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers.

Authors:  Adrien Tissot; Richard Danger; Johanna Claustre; Antoine Magnan; Sophie Brouard
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

6.  Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report.

Authors:  Hrishikesh S Kulkarni; Janet S Lee; Julie A Bastarache; Wolfgang M Kuebler; Gregory P Downey; Guillermo M Albaiceta; William A Altemeier; Antonio Artigas; Jason H T Bates; Carolyn S Calfee; Charles S Dela Cruz; Robert P Dickson; Joshua A Englert; Jeffrey I Everitt; Michael B Fessler; Andrew E Gelman; Kymberly M Gowdy; Steve D Groshong; Susanne Herold; Robert J Homer; Jeffrey C Horowitz; Connie C W Hsia; Kiyoyasu Kurahashi; Victor E Laubach; Mark R Looney; Rudolf Lucas; Nilam S Mangalmurti; Anne M Manicone; Thomas R Martin; Sadis Matalon; Michael A Matthay; Daniel F McAuley; Sharon A McGrath-Morrow; Joseph P Mizgerd; Stephanie A Montgomery; Bethany B Moore; Alexandra Noël; Carrie E Perlman; John P Reilly; Eric P Schmidt; Shawn J Skerrett; Tomeka L Suber; Charlotte Summers; Benjamin T Suratt; Masao Takata; Rubin Tuder; Stefan Uhlig; Martin Witzenrath; Rachel L Zemans; Gutavo Matute-Bello
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 7.748

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.